AQP4 and myeloid sarcoma: MOGAD has a prevalence in the United Kingdom of ~2 per 100,000 individuals,6 has no convincing sex nor racial predominance (in contrast to MS and AQP4‐antibody disease), and can present at any age.2, 3, 4